Dr. Bona is an Assistant Professor of Pediatrics at Harvard Medical School and an Attending Pediatric Oncologist at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. She received her bachelor’s degree from Cornell University, her Doctor of Medicine from the Yale University School of Medicine, and her Master of Public Health from the Harvard T.H. Chan School of Public Health. She completed pediatrics residency at Boston Children’s Hospital and Boston Medical Center and subspecialty fellowship training in pediatric hematology/oncology at Dana-Farber/Boston Children’s Hospital.

Dr. Bona’s NIH and foundation-funded research lab aims to improve survival in pediatric cancer by systematically considering social determinants of health as risk factors for poor outcome and integrating them into the existing robust clinical trial and basic science models of discovery and care in pediatric cancer. Her current research funded by the NCI and American Cancer Society includes (1) the first prospective trial-embedded investigations of poverty and outcome in both the Children’s Oncology Group and the Dana-Farber ALL Consortium; (2) development of novel health equity interventions targeting poverty-exposures designed to scale across multi-center clinical trials; and (3) collaborative translational investigations of poverty-associated treatment resistance.

Dr. Bona serves as the Director of the Pediatric Hematology/Oncology Outcomes Science Program for the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, and the inaugural Vice Chair for Health Equity for the Children’s Oncology Group ALL Committee. She is the recipient of several past awards and honors including annual teaching awards from the Boston Combined Residency Program since 2018.